SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Briefs

Advertisement


Inside Views

Contribute your views! Submit an Inside Views idea to info [at] ip-watch [dot] ch.

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Occupy IP: New Economy Businesses Clash With Old

It may be too much, too late for content providers finally trying to tame the internet, and a fresh approach is needed, writes Bruce Berman.




Special Reports

Non-Communicable Diseases Issue Energises Public Health Policymakers Read More >


Latest Comments
  • Copyrights are unique works set in a concrete mode... »
  • I deeply apprecite the initiative to combat agains... »

  • For IPW Subscribers
    A guide to Geneva-based public health and intellectual property organisations. Read More >

    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >


    Under Scrutiny, WHO, Pharma Seek To Explain “Dangerous Nonsense” Of Pandemic

    Published on 26 January 2010 @ 7:28 pm

    By , Intellectual Property Watch

    Representatives of the World Health Organization and the European pharmaceutical industry today answered charges from the Council of Europe and the press on whether they had mishandled an outbreak of influenza last summer.

    The declaration of the pandemic was “an incomprehensible action that cannot be supported by any evidence,” said Wolfgang Wodarg, a medical doctor with a specialisation in epidemiology and the former chair of the Sub-committee on Health of the Parliamentary Assembly of the Council of Europe. Wodarg was the leading signatory of a motion for investigation of the WHO by the Council of Europe, an intergovernmental body dedicated to the promotion of human rights and other issues.

    The H1N1 virus (so-called swine flu) is not a genuine threat to public health, and this was widely known as early as April 2009, contended Wodarg, raising the concern that a pandemic was declared in June primarily to push massive government procurement of patented vaccines. These vaccines that were then rushed to market with inadequate testing might themselves pose a threat to public health, he said.

    Wodarg called for an investigation to determine how this “dangerous nonsense” occurred.

    But the current pandemic is “a scientifically well-documented event [and] not an arbitrary matter of wordsmithing or polemics,” countered Keiji Fukuda, the special adviser to the WHO director general on pandemic influenza. WHO is confident of integrity and scientific validity of its thinking, said Fukuda, adding this thinking was explained in a posting on the WHO website on 3 December.

    They were speaking at a public hearing held 26 January in Strasbourg at the Council of Europe to discuss Wodarg’s motion.

    At the hearing, Wodarg also argued that access to vaccines should not be restricted by patents, which “have no place in the area of vital medications for human beings.” Such drugs should be financed by taxation income, which Wodarg said is a human rights issue related to the right to health.

    Pharma: Motion “Inappropriate”

    “In our view the terms of this motion are inappropriate for those who understand how” vaccine manufacture works, said Luc Hessel, a representative of European Vaccine Manufacturers. An EVM press release on the hearing is available here [pdf].

    The vaccine industry did what was asked of them by policymakers, said Hessel. This included major investments on their part to create the vaccines, as well as the donation of 160 million doses for use in developing countries. As to profit motive, Hessel said it was still too early to determine what kind of profit had been made by industry. And most purchasing agreements were made in the third quarter of 2009, after the declaration of the pandemic, so ex ante motivation is not there.

    Also, he said, quick vaccine production does not mean insufficient testing. The industry had 60 years of experience and 10 years of preparation to make a pandemic vaccine, and it was from this technology base they were working.

    Gigantic Misallocation of Public Health Resources?

    Ulrich Keil, a professor and the director of the WHO Collaborating Centre for Epidemiology of the University of Münster (Germany) said the H1N1 virus had been known for decades, and that so-called Asian swine flu was carried back to the United States in the 1970s from Vietnam, at which point a huge vaccination campaign was initiated and then quickly stopped when it was realised the vaccine had more negative effects – including neurological symptoms such as paralysis – than the virus.

    This “epidemic that never was” was borne of “overconfidence extrapolated from meagre evidence, personal agendas, and premature commitments,” said Keil. Obviously, he added, “those lessons were never learned.”

    Hessel would not provide a clear answer to the question of whether or not they had known about the virus, but Fukuda said it was a new strain.

    We are “presently witnessing a gigantic misallocation of public resources in health,” said Keil, as this issue is getting far more investment than non-communicable diseases, which are much more widespread killers.

    One Council of Europe parliamentarian in the audience countered that as a defender of the population he preferred the cautionary approach. “If one person died without vaccine we’d be criticised,” he said, adding “and I have no shares in the pharma industry.”

    And “history has shown that influenza pandemics can range in their impact, but that predicting what they will look like” at the beginning is “nearly impossible,” said Fakuda.

    What was clear, said Fukuda, is that human antibodies against influenza were not reacting to the virus, and that there was a person-to-person spread with early cases causing severe respiratory illnesses and death.

    A parliamentarian in the audience criticised the “over hysterical way the WHO responded to doubt” about its conclusions, “as though it couldn’t handle questions on its authorities.”

    “I find it offensive that an organisation like yours would think you are beyond
    reproach and beyond questioning,” he added.

    Communication And Preventing Conflict

    “It’s clear we can do better. The question is how do you do better?” said Fukuda, who added WHO was “under no illusions that this response was a perfect response.”

    But “when you have a person with chest pain, you don’t typically wait until it’s very severe before we do something… this is the same approach.”

    Wodarg said his “concerns have merely been strengthened” listening to WHO, and asked why the definition of a pandemic had been changed to remove the “seriousness” as a condition. Intellectual Property Watch covered this question yesterday (IPW, WHO, 25 January 2010).

    The issue was also raised by an audience member that the pandemic – and potential problems in WHO handling – were exaggerated by a scandal-mongering media. This concern had also come up during the WHO Executive Board meeting, which ran from 18-23 January.

    A representative of the UN press corps said the “WHO is the worst in terms of relations with the media. They are constantly derelict. We run after you constantly to get information. In defence of the media, we don’t have access to information.” If reporting has been inaccurate, he said, this is “largely attributable to the WHO’s aloofness and even silence.”

    Fukuda said the WHO’s work was stressful and difficult but that he hoped “we can really improve our ability to give information and to give it in a timely way.”

    Kaitlin Mara may be reached at kmara@ip-watch.ch.

     

    Comments

    1. Miles Teg says:

      What a nice bun fight! Pity the EU is only asking about WHO and not focussing on weather WHO ensured that poor countries had access to the vaccines. Assuming what they say about H1N1 is true and the pandemic was as serious as it was made out to be, then global access was what WHO would have supported. Only 2 countries are actually ready to receive vaccines from WHO stockpiles. But hey since Wall Street’s profit-at-any-cost is infectious WHO was also victim. No use selling product to countries who can’t pay, right? EVEN if it is a pandemic!
      And to add insult to injury, Fakuda says that this virus is adaptive and can mutate very fast – so it is dangerous. If that is the case, then why did the WHO/WTO/OIE issue a statement saying that Swine Flu (which they tried to rebrand H1N1 at the “behest” of the Pork Industry) poses no health risks to international trade in pork meat? If the virus is mutating, then surely more caution was required? Would Chan waive diplomatic immunity if things turned out worse than anticipated and the virus became “animal borne”?
      And also, WHO was kind to the airline industry. Its assessment of the situation did not warrant a travel ban. After all, this was a pandemic easily spread and it could not be contained so better close schools rather than airports.
      And why does the WHO come out in support of the pork industry with WTO and OIE and “fails” to support developing countries when they want to issue compulsory licenses for medicines to address morbidity and mortality?
      It seems like Alan Greenspan, Chan needs a “shock” to really understand that BigPharma is interested in profits not public health. One would have expected WHO to at least have the self-interest to protect its turf but I guess it is so mediocre that it cannot even do that.
      And on transparency, why is the WHO so Machiavelian in recognising Civil Society Groups. There are even allegations that there is “censorship” of statements that are made (or at least prior vetting). This is so unlike most other UN bodies and one can deduce that current “watchdog functions” over it fail miserably.

      What a complex web WHO weaves…

    2. Harrabin’s Notes: IPCC under scrutiny – BBC News | .:: MrCoi Blog ::. says:

      [...] Intellectual Property Watch » Blog Archive » Under Scrutiny, WHO … [...]


    Leave a Reply

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website. By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

    By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

    2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

    3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

    4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

    5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

    6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

    7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

    8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

    9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.